CD44 and breast carcinoma: A study in 2006 assessed MCF7 and MDA-MB-231 breast cancer cell lines grown in 2D culture compared to CD44+ve/CD24−ve subpopulations grown in mammosphere assays after exposure to different amounts of radiation.